NEW DELHI — In a major clarification for the burgeoning cosmetic industry, the National Consumer Disputes Redressal Commission (NCDRC) has ruled that the mere absence of desired results in hair regrowth treatments does not constitute medical negligence. The judgment, delivered in late April 2026, sets a high bar for compensation claims based solely on aesthetic dissatisfaction.
The Verdict: Biology Over Promises
The bench, led by AVM J. Rajendra (Retd) and Justice Anoop Kumar Mendiratta, overturned previous orders that had awarded ₹6 lakh in compensation to an advocate over a failed Platelet-Rich Plasma (PRP) therapy. The commission emphasised that:
- Variable Outcomes: Hair regrowth treatments like PRP depend heavily on an individual’s biological response.
- No Deviation, No Negligence: Without expert evidence showing a deviation from accepted medical standards, a “failed” outcome cannot be equated with deficiency in service.
- Informed Consent: Since the complainant—an educated professional—had signed informed consent forms outlining variable results, the claim of misrepresentation was dismissed.
When Does Failure Become Negligence?
While “lack of results” is not negligence, courts have identified specific scenarios where patients can successfully sue:
- Unfair Trade Practices: Clinics that use “guaranteed hair or money back” advertisements may be held liable for deceptive marketing, even if the procedure itself wasn’t negligent.
- Surgical Errors: In hair transplants, negligence can be proven if a surgeon over-harvests the donor area, leaving new bald patches, or delegates the surgery to unqualified technicians.
- Lack of Licensing: Performing modern scientific hair procedures without requisite government authorisations or specialized medical expertise is often deemed a “deficiency in service”.
A Rising Trend in Litigation
The ruling comes amid a surge in “medico-aesthetic” lawsuits. In recent months, clinics in Ahmedabad and Delhi have been ordered to pay up to ₹6.3 lakh in cases involving “botched” surgeries or misleading advertisements. However, legal experts note that for non-surgical treatments like PRP, the NCDRC’s latest stance provides a significant shield for practitioners who follow standard protocols.
